Cargando…
Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats
BACKGROUND: Parkinson's disease (PD) is a common neurological degenerative disease that cannot be completely cured, although drugs can improve or alleviate its symptoms. Optogenetic technology, which stimulates or inhibits neurons with excellent spatial and temporal resolution, provides a new i...
Autores principales: | Zhao, Zongya, Niu, Yanxiang, Chen, Peiqi, Zhu, Yu, Shi, Liangliang, Zhao, Xuewei, Wang, Chang, Zhang, Yehong, Gao, Zhixian, Jiang, Wenshuai, Ren, Wu, Gu, Renjun, Yu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342173/ https://www.ncbi.nlm.nih.gov/pubmed/34367273 http://dx.doi.org/10.1155/2021/9938566 |
Ejemplares similares
-
Downregulation of PACAP and the PAC1 Receptor in the Basal Ganglia, Substantia Nigra and Centrally Projecting Edinger–Westphal Nucleus in the Rotenone model of Parkinson’s Disease
por: Fehér, Máté, et al.
Publicado: (2023) -
Neutrophil‐to‐Lymphocyte ratio on admission predicts gastrointestinal bleeding in acute basal ganglia hemorrhage
por: Jiang, Xuewei, et al.
Publicado: (2022) -
Optogenetic Stimulation in a Computational Model of the Basal Ganglia Biases Action Selection and Reward Prediction Error
por: Berthet, Pierre, et al.
Publicado: (2014) -
Emergence of lesions outside of the basal ganglia and irreversible damage to the basal ganglia with severe β-ketothiolase deficiency: A case report
por: Guo, Jun, et al.
Publicado: (2021) -
The basal ganglia VII /
Publicado: (2002)